*By Tanaya Macheel and Jacqueline Corba* Crypto start-up Compound launched money markets for Ethereum assets on Thursday. "This allows pretty much anybody, anywhere in the world at anytime to earn interest on their Ethereum assets with a secure protocol," Compound co-Founder and CEO Robert Leshner told Cheddar's Crypto Craze. "So if you hold Ether, if you hold a series of tokens that we're supporting, there's incremental returns." Leshner said this open source protocol is built on Ethereum, and everything is managed directly through a smart contract. Compound's product initially supports Ether, 0x Protocol, Basic Attention Token, and Augur. And the company's ultimate goal is to create an easy-to-use money market for investors looking to tap into this emerging market. Crypto giant Coinbase participated in Compound's $8.2 million seed funding round back in May. "I believe they invested, because Compound fits in with their vision of opening up access to finance to pretty much everybody around the world," Leshner said. Other investors in the company include Andreessen Horowitz, Polychain Capital, and Bain Capital Ventures. For full interview [click here](https://cheddar.com/videos/compound-launches-money-markets-for-ethereum-assets).

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More